1801 CALIFORNIA STREET,SUITE 5200
DENVER , CO, 80202

Rank

Rank Universe

Summary

The fund seeks to appreciate capital through investing in companies in the developed markets of Asia and Europe and emerging markets.

The fund is sub-advised by TDAM USA Inc

The investment process starts with a list of companies in the benchmark MSCI EAFE Index and the research team narrows the list using fundamental research and earnings analysis and growth outlook.

The team then looks at individual companies to More

Link

Directors

Jan 10, 2024
  • Kent Callahan
  • Marijn P. Smit
  • Lauriann C. Kloppenburg
  • Kathleen T. Ives
  • John E. Pelletier
  • Patricia L. Sawyer
  • John W. Waechter
  • Alan F. Warrick
  • Fredric A. Nelson III
  • Sandra N. Bane
  • Leo J. Hill

Chief Compliance Officer

  • Francine J. Rosenberger

Fund Manager(s)

Price

  • $ 8.01 ( +0 )
    Nov 1, 2024
    Last Close
  • Net Assets
  • $391.3M
    Mar 28, 2024
  • Holding
  • 48
    Sep 25, 2024
    More

  • 52-Week High/Low
  • $8.68 - $7.66
  • Turnover
  • 36%
  • Expense Ratio
  • 0.92%

Company Name

Holding

Novo Nordisk A/S 3.8 %
ASML Holding NV 3.5 %
Shell PLC 2.75 %
Sanofi SA 2.69 %
ITOCHU Corp 2.62 %
Tokyo Electron Ltd 2.54 %
TotalEnergies SE 2.52 %
Tokio Marine Holdings Inc 2.51 %
Vinci SA 2.51 %
National Australia Bank Ltd 2.49 %
More 2.49 %

Documents

Prospectus

Annual Reports

Fact Sheet

Q2 2021

Performance

YTD

5.1%

3 Year

-22.08%

5 Year

5.53%

Best

25.12%

2019

Worst

-21.64%

2022

Alpha

TGRGX S&P 500

Chart +